Quintero-Osuna JJ, Bolívar-Rodríguez MA, Servín-Uribe SD, Cázarez-Aguilar MA, Villagómez-Urquídez RK, Herrera-Aros Y

Language: Spanish
References: 20
Page: 233-241
PDF size: 726.60 Kb.

ABSTRACT

Introduction: ASIA syndrome was described by Shoenfeld and Agmon-Levin in 2011 as a response to various autoimmune/inflam-matory pathologies developed by patients with a genetic predisposition in response to contact with various environmental stimuli and adjuvants, substances and prosthetic materials used for therapeutic and cosmetic purposes. Clinical case: A 41-year-old female, allergic to penicillin, smoker and hypothyroid, with a history of application of “biopolymers” in the gluteal region and liposculpture, who presented pain, edema and increased volume in the hips and buttocks, due to nodular and irregular tumors associated with arthralgias, asthenia, chronic fatigue, difficulty falling asleep and multiple mood swings. therefore, she underwent surgery for resection of tumors with significant improvement in symptoms after the procedure. Conclusion: ASIA Syndrome is still a poorly understood pathology, with non-specific symptoms, so its diagnosis should be ap-proached with a high degree of clinical suspicion in patients exposed to adjuvants.

REFERENCES

1. Shoenfeld Y, Agmon-Levin N. 'ASIA' - autoim-mune/inflammatory syndrome induced by adju-vants. J Autoimmun. 2011;36(1):4-8.

2. Alijotas-Reig J, García-Gimenez V, Llurba E, Vi-lardell-Tarrés M. Autoimmune/inflammatory syn-drome (ASIA) induced by biomaterials injection other than silicone medical grade. Lupus. 2012;21(12):1326-34.

3. Torres GB, Burgos BR, Medrano RG, Priego BRB. Instrumento para evaluar y estadificar el daño producido por la infiltración de sustancias modelantes Cir Plast 2010;20(3):105-11.

4. Murillo-Godínez G. Uso ilícito de modelantes y efectos adversos. Med Int Mex 2010;26(4):346-9.

5. Gordillo-Hernández J, Alegre-Tamez E., Torres-Baltazar I, Mendieta-Espinosa MJ., Sastré-Ortiz N. Abordaje multidisciplinario de la enfermedad humana por infiltración de sustancias modelan-tes. Cir Plást Iberolatinoam. 2013;39(3):269-77.

6. Contreras-Díaz BR, Córdova-Gómez A, Rubio-Gómez L, Contreras-Ruiz Velasco R. Enferme-dad por modelantes, síndrome autoinmune indu-cido por adyuvantes y otras enfermedades de la vanidad. Cir Gen. 2021;43(4):234-42.

7. The International Society of Aesthetic Plastic Surgery (ISAPS). International Survey on Aest-hetic/Cosmetic Procedures [Internet]. Nueva Jersey; ISAPS; 2021. [citado 15 de agosto de 2024]. Disponible en: https://www.isaps.org/me-dia/vdpdanke/isaps-global-survey_2021.pdf

8. Tamayo CAM, Estévez TMH, Alvarado SR, Chong LA. Síndrome autoinmune inflamatorio inducido por adyuvante después de la adminis-tración de un agente modelante con sintomato-logía de fibromialgia. Rev Colomb Reumatol. 2019;26(2):145-47.

9. Domínguez CLG, Arellano AJG. Síndrome auto-inmune inflamatorio inducido por adyuvantes (ASIA): Síndrome de Shoenfeld. Acta Med. 2022;20(1):96-8.

10. Gonzalez-Rendon MG, Larrazabal A, Suárez Á, Gutierrez C, Ortiz-Caceres W, de Waard JH, et al. Síndrome autoinmune/autoinflamatorio indu-cido por adyuvantes (ASIA) en pacientes derma-tológicas a los cinco años posteriores a la colo-cación de material de relleno con fines cosméti-cos. Med Cutan Iber Lat Am. 2019;47(1):34-8.

11. Bragazzi NL, Hejly A, Watad A, Adawi M, Amital H, Shoenfeld Y. ASIA syndrome and endocrine autoimmune disorders. Best Pract Res Clin En-docrinol Metab. 2020;34(1):101412.

12. Watad A, Bragazzi NL, McGonagle D, Adawi M, Bridgewood C, Damiani G, et al. Autoimmune/in-flammatory syndrome induced by adjuvants (ASIA) demonstrates distinct autoimmune and autoinflammatory disease associations accor-ding to the adjuvant subtype: Insights from an analysis of 500 cases. Clin Immunol 2019;203:1-8.

13. Cohen Tervaert JW, Martinez-Lavin M, Jara LJ, Halpert G, Watad A, Amital H, et al. Autoim-mune/inflammatory syndrome induced by adju-vants (ASIA) in 2023. Autoimmun Rev. 2023;22(5):103287.

14. Alijotas-Reig J. Human adjuvant-related syn-drome or autoimmune/inflammatory syndrome induced by adjuvants. Where have we come from? Where are we going? A proposal for new diagnostic criteria. Lupus. 2015;24(19):1012-8.

15. Montealegre G, Uribe R, Martínez-Ceballos MA, Rojas-Villarraga A. ASIA syndrome symptoms induced by gluteal biopolymer injections: Case-series and narrative review. Toxicol Rep. 2021;8:303-14.

16. Paipilla-Sandoval M, Sarmiento-Pardo P, La-rrarte-Arenas D, Cortes-Fonseca D, Camargo-Gonzales DF, Halliday Rueda A. Síndrome de ASIA, una patología desconocida. Rev Col Cir Plast Reconstr. 2022;28(1):42-8.

17. López-Mendoza FJ, Moran-Romero M, Mouneu N. Outcomes and complications of surgical re-moval of foreign body granulomas due to illicit polymer injection for cosmetic purposes. Aesthet Surg J. 2021;41(9):NP1176–NP1187.

18. Caravantes-Cortes MI, Roldan-Valadez E, Zwojewski-Martinez RD, Salazar-Ruiz SY, Car-ballo-Zarate AA. Breast prosthesis syndrome: Pathophysiology and management algorithm. Aesthetic Plast Surg. 2020;44(5):1423-37.

19. Tamayo-Carbón AM, Orozco-Jaramillo MA, Po-sada-Ruiz DA. Sustancias adyuvantes y sín-drome autoinmune inflamatorio inducido por ad-yuvantes. Presentación de un caso. Rev Panor. 2020;15(1):59-64.

20. Atiyeh B, Emsieh S. Breast implant illness (BII): Real syndrome or a social media phenomenon? A narrative review of the literature. Aesthetic Plast Surg. 2022;46(1):43-57.